| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 193 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 193 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 193 |
| 3 | DOXORUBICIN | 179 |
| 4 | DEXAMETHASONE | 162 |
| 5 | DEXAMETHASONE 1.5 MG | 162 |
| 6 | RITUXIMAB | 157 |
| 7 | ETOPOSIDE | 136 |
| 8 | PREDNISONE | 109 |
| 9 | DOCETAXEL | 100 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GRANULOCYTE COLONY STIMULATING FACTOR | 17 | 0.0078 |
| 1 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 1 | 0.0067 |
| 2 | BLEOMYCIN SULFATE | 67 | 0.0065 |
| 3 | ANIDULAFUNGIN | 9 | 0.0055 |
| 4 | GEMTUZUMAB OZOGAMICIN | 17 | 0.0046 |
| 5 | CHLORAMBUCIL | 18 | 0.0046 |
| 6 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0040 |
| 7 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 8 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 13 | 0.0039 |
| 9 | BENZOCAINE AND MENTHOL | 1 | 0.0038 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 366 |
| 1 | Alkylating Drug [EPC] | 260 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 188 |
| 3 | Platinum-based Drug [EPC] | 180 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 160 |
| 5 | Topoisomerase Inhibitor [EPC] | 142 |
| 6 | Microtubule Inhibitor [EPC] | 134 |
| 7 | Leukocyte Growth Factor [EPC] | 107 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 87 |
| 9 | Azole Antifungal [EPC] | 80 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 17 | 0.0046 |
| 1 | Topoisomerase Inhibitor [EPC] | 142 | 0.0018 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 2 | 0.0013 |
| 3 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 5 | 0.0012 |
| 4 | Echinocandin Antifungal [EPC] | 10 | 0.0012 |
| 5 | Alkylating Drug [EPC] | 260 | 0.0011 |
| 6 | CD30-directed Immunoconjugate [EPC] | 11 | 0.0011 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 65 | 0.0009 |
| 8 | Lipopeptide Antibacterial [EPC] | 8 | 0.0008 |
| 9 | Microtubule Inhibitor [EPC] | 134 | 0.0008 |